554 related articles for article (PubMed ID: 27738139)
1. The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair.
Roos WP; Krumm A
Nucleic Acids Res; 2016 Dec; 44(21):10017-10030. PubMed ID: 27738139
[TBL] [Abstract][Full Text] [Related]
2. Interstrand Crosslink Repair as a Target for HDAC Inhibition.
Nikolova T; Kiweler N; Krämer OH
Trends Pharmacol Sci; 2017 Sep; 38(9):822-836. PubMed ID: 28687272
[TBL] [Abstract][Full Text] [Related]
3. Sirtuins (histone deacetylases III) in the cellular response to DNA damage--facts and hypotheses.
Kruszewski M; Szumiel I
DNA Repair (Amst); 2005 Nov; 4(11):1306-13. PubMed ID: 16084131
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.
Groselj B; Sharma NL; Hamdy FC; Kerr M; Kiltie AE
Br J Cancer; 2013 Mar; 108(4):748-54. PubMed ID: 23361058
[TBL] [Abstract][Full Text] [Related]
5. Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage.
Fukuda T; Wu W; Okada M; Maeda I; Kojima Y; Hayami R; Miyoshi Y; Tsugawa K; Ohta T
Cancer Sci; 2015 Aug; 106(8):1050-6. PubMed ID: 26053117
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity.
Smith S; Fox J; Mejia M; Ruangpradit W; Saberi A; Kim S; Choi Y; Oh S; Wang Y; Choi K; Li L; Hendrickson EA; Takeda S; Muller M; Myung K
PLoS One; 2014; 9(1):e87203. PubMed ID: 24466340
[TBL] [Abstract][Full Text] [Related]
7. The interplay between DNA repair and autophagy in cancer therapy.
Zhang D; Tang B; Xie X; Xiao YF; Yang SM; Zhang JW
Cancer Biol Ther; 2015; 16(7):1005-13. PubMed ID: 25985143
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylases enhances DNA damage repair in SCNT embryos.
Bohrer RC; Duggavathi R; Bordignon V
Cell Cycle; 2014; 13(13):2138-48. PubMed ID: 24841373
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance.
Krumm A; Barckhausen C; Kücük P; Tomaszowski KH; Loquai C; Fahrer J; Krämer OH; Kaina B; Roos WP
Cancer Res; 2016 May; 76(10):3067-77. PubMed ID: 26980768
[TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
Robert C; Nagaria PK; Pawar N; Adewuyi A; Gojo I; Meyers DJ; Cole PA; Rassool FV
Leuk Res; 2016 Jun; 45():14-23. PubMed ID: 27064363
[TBL] [Abstract][Full Text] [Related]
12. Characterization of valproic acid-initiated homologous recombination.
Sha K; Winn LM
Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):124-32. PubMed ID: 20437471
[TBL] [Abstract][Full Text] [Related]
13. Autophagy Roles in the Modulation of DNA Repair Pathways.
Gomes LR; Menck CFM; Leandro GS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112132
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin inhibition increases the rate of non-homologous end-joining of DNA double strand breaks.
Wojewódzka M; Kruszewski M; Buraczewska I; Xu W; Massuda E; Zhang J; Szumiel I
Acta Biochim Pol; 2007; 54(1):63-9. PubMed ID: 17311110
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Effect of Histone Deacetylase Inhibitors on DNA Double-Strand Break Repair by Nonhomologous End Joining.
Krämer OH; Diehl T; Roos WP
Methods Mol Biol; 2023; 2589():293-302. PubMed ID: 36255632
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy.
Botrugno OA; Robert T; Vanoli F; Foiani M; Minucci S
Clin Cancer Res; 2012 May; 18(9):2436-42. PubMed ID: 22512979
[TBL] [Abstract][Full Text] [Related]
17. ISWI chromatin remodeling complexes in the DNA damage response.
Aydin ÖZ; Vermeulen W; Lans H
Cell Cycle; 2014; 13(19):3016-25. PubMed ID: 25486562
[TBL] [Abstract][Full Text] [Related]
18. Localized histone acetylation and deacetylation triggered by the homologous recombination pathway of double-strand DNA repair.
Tamburini BA; Tyler JK
Mol Cell Biol; 2005 Jun; 25(12):4903-13. PubMed ID: 15923609
[TBL] [Abstract][Full Text] [Related]
19. The impact of heterochromatin on DSB repair.
Goodarzi AA; Noon AT; Jeggo PA
Biochem Soc Trans; 2009 Jun; 37(Pt 3):569-76. PubMed ID: 19442252
[TBL] [Abstract][Full Text] [Related]
20. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.
Okonkwo A; Mitra J; Johnson GS; Li L; Dashwood WM; Hegde ML; Yue C; Dashwood RH; Rajendran P
Mol Nutr Food Res; 2018 Sep; 62(18):e1800228. PubMed ID: 29924908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]